Graft Thrombosis After Endovascular Aortic Repair - a Single Center Experience With the Cook Zenith Alpha Spiral-Z®
- Conditions
- Aorta Aneurysm
- Interventions
- Procedure: Endovascular aortic repair with Zenith Alpha Spiral-Z®
- Registration Number
- NCT04564560
- Lead Sponsor
- St. Olavs Hospital
- Brief Summary
The purpose of this study is to assess the extent of thrombosis in the Zenith Alpha Spiral-Z® stent graft.
- Detailed Description
Cook Medical has reported thrombus formation with or without occlusion of the Zenith Alpha Spiral-Z®. The purpose of this study is to measure the extent of thrombus formation and occlusion of these stent graft limbs in patients with aortic aneurysms treated at St. Olavs Hospital in 2017, 2018 and 2019. Information is collected from the Norwegian registry for vascular surgery (NORKAR), electronic patient journal and the picture archiving and communication system (PACS). The total number of included patients is estimated to be approximately 100.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 161
- Patients that have received endovascular treatment with the Zenith Alpha Spiral-Z® for an aortic aneurysm
- The endovascular procedure was performed at St Olavs Hospital from January 2017 until December 2019
- None
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Patients treated with Zenith Alpha Spiral-Z® Endovascular aortic repair with Zenith Alpha Spiral-Z® Patients that from January 2017 until December 2019 received endovascular aortic repair with the Zenith Alpha Spiral-Z® at St. Olavs Hospital
- Primary Outcome Measures
Name Time Method Percentage of patients who got an amputation post-surgery due to thrombosis or occlusion of stent graft leg 12-36 months Any amputation in the affected limb / same side as thrombosed stent graft leg
Percentage of patients who have got treated post-surgery due to thrombosis or occlusion of stent graft leg 12-36 months Any endovascular or surgical procedure to treat thrombosis or occlusion
Percentage of patients who died post-surgery 12-36 months Death of any cause during the observation time
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
St Olavs Hospital, Clinic of Surgery, Clinic of Radiology and Nuclear Medicine
🇳🇴Trondheim, Norway